首页> 美国卫生研究院文献>Drug Delivery >Multi-functional chitosan copolymer modified nanocrystals as oral andrographolide delivery systems for enhanced bioavailability and anti-inflammatory efficacy
【2h】

Multi-functional chitosan copolymer modified nanocrystals as oral andrographolide delivery systems for enhanced bioavailability and anti-inflammatory efficacy

机译:多功能壳聚糖共聚物改性纳米晶体作为口服穿心莲内酯递送系统以提高生物利用度和抗炎功效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Modifying nanocrystals with functional materials have been common strategy to enlarge the enhancing ability on oral absorption via nanocrystals; however, whether the functional materials have played their full enhancing ability in oral absorption is still unknown. In this study, we synthetized a novel chitosan-based copolymer (the copolymer of sodium dodecyl sulfate (SDS), chitosan (CS) and D-α-Tocopherol polyethylene glycol 1000 succinate, SDS-CS-TPGS), and modified nanocrystals with this copolymer, aiming to enhance the oral absorption of polymer andrographolide (ADR). In real-time distribution study, we found the distribution of ADR, SDS, CS and TPGS varies in gastrointestinal tract, while the distribution of ADR and SDS-CS-TPGS was similar, revealing the SDS-CS-TPGS could able to participate in the absorption process of andrographolide timely. To explore the oral absorption enhancing ability of SDS-CS-TPGS, we prepared a series of nanocrystals modified with different materials and explored their pharmacokinetic performances on SD rats. The results showed the nanocrystals modified with SDS-CS-TPGS (S-C-TANs) exhibited the highest bioavailability, which could enhance the AUC0-∞ of ADR from 1.291 mg/L*h to 5.275 mg/L*h (enhanced for about 4.09-folds). The enhanced anti- inflammatory efficacy was also found on ICR mice by employing ear swelling rate, TNF-α, IL-1β and IL-6 and pharmacodynamic index. These results indicated that modified with synthesized copolymer containing different functional stabilizers is an efficient strategy to enlarge the enhancing ability on oral absorption of nanocrystals.
机译:用功能性材料修饰纳米晶体一直是扩大纳米晶体增强口服吸收能力的常见策略;然而,功能性材料是否在口服吸收中发挥了全部增强能力仍是未知数。在这项研究中,我们合成了一种新型壳聚糖基共聚物 (十二烷基硫酸钠 (SDS)、壳聚糖 (CS) 和 D-α-生育酚聚乙二醇 1000 琥珀酸酯的共聚物,SDS-CS-TPGS),并用该共聚物修饰了纳米晶体,旨在增强聚合物穿心莲内酯 (ADR) 的口服吸收。在实时分布研究中,我们发现 ADR、SDS、CS 和 TPGS 在胃肠道中的分布存在差异,而 ADR 和 SDS-CS-TPGS 的分布相似,揭示了 SDS-CS-TPGS 能够及时参与穿心莲内酯的吸收过程。为探究 SDS-CS-TPGS 的口服吸收增强能力,我们制备了一系列不同材料修饰的纳米晶体,并探讨了它们在 SD 大鼠身上的药代动力学性能。结果表明,SDS-CS-TPGS (S-C-TAN) 改性的纳米晶表现出最高的生物利用度,可将 ADR 的 AUC0-∞ 从 1.291 mg/L*h 提高到 5.275 mg/L*h(增强约 4.09 倍)。通过采用耳肿胀率、TNF-α、IL-1β 和 IL-6 以及药效学指数,在 ICR 小鼠上也发现了增强的抗炎效果。这些结果表明,用含有不同功能稳定剂的合成共聚物改性是扩大纳米晶体口服吸收增强能力的有效策略。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号